Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Derm innovation Hero Background

BPO for rosacea?
Tretinoin and BPO together for acne?

Now possible with patented
microencapsulation technology.1-3

Patented microencapsulation technology was designed to do
what was once thought to be impossible. This slow-release
system is unlocking new uses for 2 of dermatology's
most trusted molecules.1-3

 

BPO=benzoyl peroxide.
Not an actual patient.

Dermatology’s newest
cutting-edge technology1-3

 

MICROENCAPSULATION TECHNOLOGY WILL CHANGE THE WAY YOU
LOOK AT TRUSTED MOLECULES1-3

icon

Never before used in the
treatment of acne or
rosacea2,3

icon

Allows for controlled
release of active drugs1-3

icon

Improves tolerability of
historically irritating
medications1-3

Microencapculation technology video thumbnail

See it in action

 

met_logo

 

img

TRETINOIN & BPO COMBINED FOR ACNE

Microencapsulation
for acne

For the first time ever, tretinoin and benzoyl peroxide (BPO) have been combined into a single application for acne.2,3

SEE HOW IT WORKS

BPO FOR SENSITIVE ROSACEA SKIN

Microencapsulation for rosacea

BPO has been specifically encapsulated to help sensitive rosacea skin in a first-of-its-kind topical cream.1,4,5

SEE HOW IT WORKS
img
quote

“Microencapsulation technology is changing the way we treat our acne and rosacea patients. Never before would I have thought to prescribe some of the very effective, yet traditionally irritating, skin medications.”

doctor

 

Dr. Hilary Baldwin
Medical Director The Acne Treatment and Research Center Morristown, NJ

Stay on the cutting edge
of dermatology

 

RECEIVE THE LATEST UPDATES ON PATENTED
MICROENCAPSULATION TECHNOLOGY, INCLUDING

 

Product availability

. . . . . .

Product support online, by phone, or in person

. . . . . .

And more

I would like to learn more about microencapsulation technology product(s) for
Please check the box to confirm you have read and agree with the Terms of Use and Privacy Policy.

By completing and submitting this form, you grant permission and agree to allow Galderma Laboratories, L.P., and its affiliates (“Galderma”) to collect the information you provide so that Galderma may market or advertise to you across multiple channels regarding EPSOLAY cream. Galderma will not sell or share this information with third parties. For additional information regarding how Galderma handles your information, please see our privacy policy.

*Required.

References: 1. Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-973. doi:10.1016/j.jaad.2015.12.037 2. Del Rosso J, Levy-Hacham O, Mizrahi O. Efficacy and safety of microencapsulated benzoyl peroxide 3% and microencapsulated tretinoin 0.1% (e-bpo/e-atra) in acne vulgaris: results from two randomized controlled clinical trials. SKIN The J of Cutan Med. 2021;5(1):S24. https://doi.org/10.25251/skin.5.supp.24 3. van Zuuren EJ, Arents BWM, van der Linden MMD, Vermeulen S, Fedorowicz Z, Tan J. Rosacea: new concepts in classification and treatment. Am J Clin Dermatol. 2021;22(4):457-465. doi:10.1007/s40257-021-00595-7